Fallopian Tube Access Implant for Early Ovarian Cancer Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for ovarian cancer screening are inadequate for early detection, often leading to late-stage diagnoses, and there is a need for a screening method that targets the fallopian tubes, where high-grade serous carcinoma originates.
Innovation Solution
An implant is designed to be inserted into the uterine cavity with arms extending into the fallopian tubes, providing a working channel for an insertion instrument to collect cells, and includes a micro-robot for capturing and extracting tissues, allowing periodic screening tests.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging diagnosis (ultrasound, CT, MRI) and serum tumor marker analysis are used for ovarian cancer screening, then diagnostic capability is provided, but early detection capability is insufficient and late-stage diagnosis occurs
Solution Approach 1:
The implant is inserted into the fallopian tube before cancer development occurs, establishing a monitoring position in advance. This allows cell collection and screening to be performed before malignant transformation, enabling preliminary detection of precancerous changes and early-stage cancer that conventional methods miss
2Productivity
If repeated screening tests are performed through traditional methods, then screening frequency can be increased, but patient discomfort and procedural complexity increase
Solution Approach 1:
The implant is inserted once and remains in place to provide continuous access to the fallopian tube. Multiple screening tests can then be performed through the implant's working channel without repeated invasive insertions, allowing frequent monitoring while maintaining patient convenience
Solution Approach 2:
The implant acts as an intermediary device that provides a permanent access pathway to the fallopian tube. Instead of repeatedly inserting instruments through the cervix and uterus, the implant serves as a stable mediator that facilitates easy cell collection and screening procedures
Data Source
AI summary
The present invention relates to an implant, an ovarian cancer screening test kit comprising same, and an ovarian cancer screening test method using same, thereof wherein the implant is mounted in the uterine cavity so that the working channel maintain a path from the cervix to the fallopian tube for a predetermined period. According to the implant for screening test of ovarian cancer, the screening test kit comprising same, and the ovarian cancer screening test method using same of the present invention, the implant mounted in the uterus can be used to execute the screening test, can simply carry out periodically repeated screening tests to improve the convenience and minimize discomfort for the patient, and can allow both cystoscopy and biopsy.